1. Home
  2. ECF vs VIGL Comparison

ECF vs VIGL Comparison

Compare ECF & VIGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ECF
  • VIGL
  • Stock Information
  • Founded
  • ECF 1986
  • VIGL 2020
  • Country
  • ECF United States
  • VIGL United States
  • Employees
  • ECF N/A
  • VIGL N/A
  • Industry
  • ECF Finance/Investors Services
  • VIGL Biotechnology: Pharmaceutical Preparations
  • Sector
  • ECF Finance
  • VIGL Health Care
  • Exchange
  • ECF Nasdaq
  • VIGL Nasdaq
  • Market Cap
  • ECF 138.8M
  • VIGL 134.9M
  • IPO Year
  • ECF N/A
  • VIGL 2022
  • Fundamental
  • Price
  • ECF $10.28
  • VIGL $8.02
  • Analyst Decision
  • ECF
  • VIGL Buy
  • Analyst Count
  • ECF 0
  • VIGL 7
  • Target Price
  • ECF N/A
  • VIGL $8.00
  • AVG Volume (30 Days)
  • ECF 57.7K
  • VIGL 1.4M
  • Earning Date
  • ECF 01-01-0001
  • VIGL 08-12-2025
  • Dividend Yield
  • ECF 6.42%
  • VIGL N/A
  • EPS Growth
  • ECF N/A
  • VIGL N/A
  • EPS
  • ECF 0.46
  • VIGL N/A
  • Revenue
  • ECF N/A
  • VIGL N/A
  • Revenue This Year
  • ECF N/A
  • VIGL N/A
  • Revenue Next Year
  • ECF N/A
  • VIGL N/A
  • P/E Ratio
  • ECF $17.61
  • VIGL N/A
  • Revenue Growth
  • ECF N/A
  • VIGL N/A
  • 52 Week Low
  • ECF $7.02
  • VIGL $1.31
  • 52 Week High
  • ECF $8.91
  • VIGL $8.03
  • Technical
  • Relative Strength Index (RSI)
  • ECF 63.68
  • VIGL 89.24
  • Support Level
  • ECF $10.16
  • VIGL $7.86
  • Resistance Level
  • ECF $10.32
  • VIGL $7.96
  • Average True Range (ATR)
  • ECF 0.09
  • VIGL 0.03
  • MACD
  • ECF -0.00
  • VIGL -0.16
  • Stochastic Oscillator
  • ECF 81.93
  • VIGL 83.33

About ECF Ellsworth Growth and Income Fund Ltd.

Ellsworth Growth and Income Fund Ltd operate as a closed-end, diversified management investment company. Its investment objective is to provide income and the potential for capital appreciation, which objectives the Fund considers to be relatively equal over the long term due to the nature of the securities in which it invests. The company invests in convertible and equity securities. It invests in various sectors, such as healthcare, financial services, computer software and services, energy and utilities, real estate investment trusts, semiconductors, telecommunications, business services, food and beverage, consumer products, transportation, consumer services among others.

About VIGL Vigil Neuroscience Inc.

Vigil Neuroscience Inc is a clinical-stage biotechnology company engaged in improving the lives of patients, caregivers, and families affected by rare and common neurodegenerative diseases by pursuing the development of disease-modifying therapeutics to restore the vigilance of microglia. Microglia are the sentinel immune cells of the brain and play a critical role in maintaining central nervous system (CNS) health and responding to damage caused by disease. The group provides solutions for fully human monoclonal antibody and Oral small molecule TERM2 agonist.

Share on Social Networks: